Sequana Medical NV Statistics
Total Valuation
Sequana Medical NV has a market cap or net worth of EUR 37.27 million. The enterprise value is 52.20 million.
Market Cap | 37.27M |
Enterprise Value | 52.20M |
Important Dates
The next estimated earnings date is Thursday, September 19, 2024.
Earnings Date | Sep 19, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Sequana Medical NV has 40.24 million shares outstanding.
Shares Outstanding | 40.24M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 10.33% |
Owned by Institutions (%) | 21.87% |
Float | 22.32M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 34.81 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.60 |
EV / Sales | 73.30 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -1.75 |
Financial Position
The company has a current ratio of 0.32
Current Ratio | 0.32 |
Quick Ratio | 0.15 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -0.59 |
Interest Coverage | -14.82 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -102.04% |
Return on Capital (ROIC) | -273.20% |
Revenue Per Employee | 11,487 |
Profits Per Employee | -525,219 |
Employee Count | 62 |
Asset Turnover | 0.04 |
Inventory Turnover | 0.07 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.70% in the last 52 weeks. The beta is 0.84, so Sequana Medical NV's price volatility has been lower than the market average.
Beta (5Y) | 0.84 |
52-Week Price Change | -72.70% |
50-Day Moving Average | 1.10 |
200-Day Moving Average | 2.11 |
Relative Strength Index (RSI) | 37.87 |
Average Volume (20 Days) | 21,457 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sequana Medical NV had revenue of EUR 712,173 and -32.56 million in losses. Loss per share was -1.22.
Revenue | 712,173 |
Gross Profit | 548,049 |
Operating Income | -29.49M |
Pretax Income | -32.10M |
Net Income | -32.56M |
EBITDA | -29.14M |
EBIT | -29.49M |
Loss Per Share | -1.22 |
Balance Sheet
The company has 2.58 million in cash and 17.52 million in debt, giving a net cash position of -14.94 million or -0.37 per share.
Cash & Cash Equivalents | 2.58M |
Total Debt | 17.52M |
Net Cash | -14.94M |
Net Cash Per Share | -0.37 |
Equity (Book Value) | -19.47M |
Book Value Per Share | -0.69 |
Working Capital | -13.17M |
Cash Flow
In the last 12 months, operating cash flow was -29.06 million and capital expenditures -710,754, giving a free cash flow of -29.77 million.
Operating Cash Flow | -29.06M |
Capital Expenditures | -710,754 |
Free Cash Flow | -29.77M |
FCF Per Share | -0.74 |
Margins
Gross Margin | 76.95% |
Operating Margin | -4,141.05% |
Pretax Margin | -4,507.05% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -4,180.74% |
Dividends & Yields
Sequana Medical NV does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -131.34% |
FCF Yield | -79.90% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |